Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
RIGEL PHARMACEUTICALS INC (RIGL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/12/2023 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| MOOS WALTER H (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| Wasman Jane (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| Ali-Jackson Kamil (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| LYONS GARY A (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| Kotzin Brian L. (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/12/2023 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 02/07/2023 |
4
| RODRIGUEZ RAUL R (CEO, President) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 300,000 shares
@ $0
Sold 20,340 shares
@ $1.75, valued at
$35.6k
Granted 600,000 options to buy
@ $1.87, valued at
$1.1M
|
|
| 02/06/2023 |
4
| Santos David A (EVP, Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Sold 5,388 shares
@ $1.6602, valued at
$8.9k
|
|
| 02/06/2023 |
4
| Schorno Dean L (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Sold 5,389 shares
@ $1.6601, valued at
$8.9k
|
|
| 02/06/2023 |
4
| Dummer Wolfgang (EVP & CMO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Sold 5,389 shares
@ $1.6601, valued at
$8.9k
|
|
| 01/30/2023 |
4
| Dummer Wolfgang (EVP & CMO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options to buy
@ $2.42, valued at
$121k
|
|
| 01/30/2023 |
4
| RODRIGUEZ RAUL R (CEO, President) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $2.42, valued at
$484k
|
|
| 01/30/2023 |
4
| Schorno Dean L (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 63,000 shares
@ $0
Granted 50,000 options to buy
@ $2.42, valued at
$121k
Granted 125,000 options to buy
@ $1.87, valued at
$233.8k
|
|
| 01/30/2023 |
4
| Santos David A (EVP, Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 80,000 shares
@ $0
Granted 50,000 options to buy
@ $2.42, valued at
$121k
Granted 160,000 options to buy
@ $1.87, valued at
$299.2k
|
|
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2022 |
4
| VANCE DOLLY (EVP Corp. Affairs, G.C., Sect.) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 81,250 options to buy
@ $2, valued at
$162.5k
|
|
| 09/16/2022 |
4
| RODRIGUEZ RAUL R (CEO, President) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 300,000 options to buy
@ $2, valued at
$600k
|
|
| 09/16/2022 |
4
| Schorno Dean L (EVP & CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 81,250 options to buy
@ $2, valued at
$162.5k
|
|
| 06/13/2022 |
4
| RODRIGUEZ RAUL R (CEO, President) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Bought 1,000,000 shares
@ $0.6884, valued at
$688.4k
|
|
| 05/23/2022 |
4
| MOOS WALTER H (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $2.01, valued at
$60.3k
|
|
| 05/23/2022 |
4
| Wasman Jane (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $2.01, valued at
$60.3k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| LYONS GARY A (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $2.01, valued at
$60.3k
|
|
| 05/23/2022 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $2.01, valued at
$60.3k
|
|
| 05/23/2022 |
4
| Ali-Jackson Kamil (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 18,750 shares
@ $0
Granted 22,500 options to buy
@ $2.01, valued at
$45.2k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2022 |
4
| Schorno Dean L (EVP &CFO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 50,000 shares
@ $0
Granted 100,000 options to buy
@ $2.42, valued at
$242k
|
|
| 01/26/2022 |
4
| Dummer Wolfgang (EVP & CMO) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 50,000 shares
@ $0
Granted 100,000 options to buy
@ $2.42, valued at
$242k
|
|
| 01/26/2022 |
4
| Santos David A (EVP, Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 50,000 shares
@ $0
Granted 100,000 options to buy
@ $2.42, valued at
$242k
|
|
| 01/26/2022 |
4
| RODRIGUEZ RAUL R (CEO, President) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 200,000 shares
@ $0
Granted 400,000 options to buy
@ $2.42, valued at
$968k
|
|
|
|
|